“These initial results suggest that individuals with SCD have a significantly higher cellular senescence burden which may contribute to premature aging, physiological decline, and excess morbidities" ...
CHICAGO, December 13, 2023 (Newswire.com) - The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the US Food and Drug Administration's (FDA) recently granted approval for ...
A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 21 on November 14, 2024, entitled, "Adolescents and ...
It’s just a discussion next week of Vertex Pharmaceuticals Inc. and Crispr Therapeutics AG’s sickle cell disease (SCD) therapy, with no vote expected from the U.S. FDA’s Cellular, Tissue and Gene ...
Gaithersburg, Maryland and Boston, MA — January 20, 2026 — Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children’s Hospital today announced a ...
Fulcrum Therapeutics, Inc. ® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with rare hematological ...
The American Society for Transplantation and Cellular Therapy is an international professional membership association. SCD is a genetically inherited red blood cell disorder. According to the Centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results